29/10/2024
ESC 2024: RESHAPE-HF2 results move conversation forward on effectiveness of TEER in functional MR
The trial’s principal investigator, Stefan Anker (Charite University Hospital, Berlin, Germany) said the findings should provide reassurance about the benefits of TEER using the MitraClip device (Abbott) in patients with moderate to severe functional MR and heart failure and could strengthen and broaden recommendations for its future use. Critics, however, are less enthusiastic about the conclusions.
Watch the full interview here:
A strategy of mitral transcatheter edge-to-edge repair (TEER) plus medical therapy in patients with heart failure and moderate to severe mitral regurgitation (MR), who were not eligible for surgery, was found to be more effective than optimal medical therapy alone, investigators in the RESHAPE-HF2 t...
